Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck (Q71647966)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1994

Language	Label	Description	Also known as
English	Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck	scientific article published on 01 July 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck (English)

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic squamous cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M. Clavel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

J. B. Vermorken

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

F. Cognetti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

P. Cappelaere

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

P. H. de Mulder

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

J. H. Schornagel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

E. A. Tueni

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

J. Verweij

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

J. Wildiers

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

M. Clerico

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7522527

15 May 2024

publication date

1 July 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

full work available at URL

https://doi.org/10.1093/oxfordjournals.annonc.a058906

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

http://annonc.oxfordjournals.org/cgi/content/abstract/5/6/521

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522527

15 May 2024

https://api.elsevier.com/content/article/PII:S0923753419631467?httpAccept=text/xml

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

https://api.elsevier.com/content/article/PII:S0923753419631467?httpAccept=text/plain

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

http://academic.oup.com/annonc/article-pdf/5/6/521/699512/5-6-521.pdf

Portable Document Format

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

521-526

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

induction chemotherapy

1

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck

5

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group Study

6

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck

7

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer

8

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck

9

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study

10

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

11

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate

12

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer

13

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

14

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

15

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

16

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

18

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

19

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058906

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058906

15 May 2024

Identifiers

10.1093/OXFORDJOURNALS.ANNONC.A058906

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7522527%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71647966&oldid=2155396007"